The human mitochondrial transport/carrier protein family. Nonsynonymous single nucleotide polymorphisms (nsSNPs) and mutations that lead to human diseases

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1757, Issue 9-10, 2006, Pages 1263-1270

  Wohlrab, Hartmut ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Carrier; Human; Mitochondria; Protein; Transport

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; CARBOXYATRACTYLOSIDE; CARRIER PROTEIN; PHOSPHATE TRANSPORTER;

AMINO ACID SEQUENCE; GENE; GENE DELETION; GENE MUTATION; GENE SEQUENCE; HUMAN; MITOCHONDRION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN STRUCTURE; REVIEW; RNA SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM; UNINDEXED SEQUENCE;

AMINO ACID SEQUENCE; HUMANS; MITOCHONDRIAL DISEASES; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MOLECULAR SEQUENCE DATA; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE;

BOS TAURUS;

EID: 33748952840     PISSN: 00052728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbabio.2006.05.024     Document Type: Review

References (42)

1. Wohlrab H. The human mitochondrial transport protein family: identification and protein regions significant for transport function and substrate specificity. Biochim. Biophys. Acta 1709 (2005) 157-168
2. Pondarre C., Antiochos B.B., Campagna D.R., Clarke S.L., Greer E.L., Deck K.M., McDonald A., Han A.P., Medlock A., Kutok J.L., Anderson S.A., Eisenstein R.S., and Fleming M.D. The mitochondrial ATP-binding cassette transporter Abcb7 is essential in mice and participates in cytosolic iron-sulphur cluster biogenesis. Hum. Mol. Genet. 15 (2006) 953-964
3. Kolisek M., Zsurka G., Samaj J., Weghuber J., Schweyen R.J., and Schweigel M. Mrs2p is an essential component of the major electrophoretic Mg2+ influx system in mitochondria. EMBO J. 22 (2003) 1235-1244
4. Kolbe H.V., and Wohlrab H. Sequence of the N-terminal formic acid fragment and location of the N-ethylmaleimide-binding site of the phosphate transport protein from beef heart mitochondria. J. Biol. Chem. 260 (1985) 15899-15906
5. Wohlrab H., Annese V., and Haefele A. Single replacement constructs of all hydroxyl, basic, and acidic amino acids identify new function and structure-sensitive regions of the mitochondrial phosphate transport protein. Biochemistry 41 (2002) 3254-3261
6. Pebay-Peyroula E., Dahout-Gonzalez C., Kahn R., Trezeguet V., Lauquin G.J., and Brandolin G. Structure of mitochondrial ADP/ATP carrier in complex with carboxyatractyloside. Nature 426 (2003) 39-44
7. Phelps A., and Wohlrab H. Homodimeric mitochondrial phosphate transport protein. Transient subunit/subunit contact site between the transport relevant transmembrane helices A. Biochemistry 43 (2004) 6200-6207
8. Wohlrab H. Novel inter- and intrasubunit contacts between transport-relevant residues of the homodimeric mitochondrial phosphate transport protein. Biochem. Biophys. Res. Commun. 320 (2004) 685-688
9. Majima E., Ikawa K., Takeda M., Hashimoto M., Shinohara Y., and Terada H. Translocation of loops regulates transport activity of mitochondrial ADP/ATP carrier deduced from formation of a specific intermolecular disulfide bridge catalyzed by copper-o-phenanthroline. J. Biol. Chem. 270 (1995) 29548-29554
10. Heisterkamp N., Mulder M.P., Langeveld A., ten Hoeve J., Wang Z., Roe B.A., and Groffen J. Localization of the human mitochondrial citrate transporter protein gene to chromosome 22Q11 in the DiGeorge syndrome critical region. Genomics 29 (1995) 451-456
11. Goldmuntz E., Wang Z., Roe B.A., and Budarf M.L. Cloning, genomic organization, and chromosomal localization of human citrate transport protein to the DiGeorge/velocardiofacial syndrome minimal critical region. Genomics 33 (1996) 271-276
12. Salvi S., Dionisi-Vici C., Bertini E., Verardo M., and Santorelli F.M. Seven novel mutations in the ORNT1 gene (SLC25A15) in patients with hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome. Human Mutat. 18 (2001) 460
13. Korman S.H., Kanazawa N., Abu-Libdeh B., Gutman A., and Tsujino S. Hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome with evidence of mitochondrial dysfunction due to a novel SLC25A15 (ORNT1) gene mutation in a Palestinian family. J. Neurol. Sci. 218 (2004) 53-58
14. Miyamoto T., Kanazawa N., Kato S., Kawakami M., Inoue Y., Kuhara T., Inoue T., Takeshita K., and Tsujino S. Diagnosis of Japanese patients with HHH syndrome by molecular genetic analysis: a common mutation, R179X. J. Hum. Genet. 46 (2001) 260-262
15. Deschauer M., Hudson G., Muller T., Taylor R.W., Chinnery P.F., and Zierz S. A novel ANT1 gene mutation with probable germline mosaicism in autosomal dominant progressive external ophthalmoplegia. Neuromuscul. Disord. 15 (2005) 311-315
16. Palmieri L., Alberio S., Pisano I., Lodi T., Meznaric-Petrusa M., Zidar J., Santoro A., Scarcia P., Fontanesi F., Lamantea E., Ferrero I., and Zeviani M. Complete loss-of-function of the heart/muscle-specific adenine nucleotide translocator is associated with mitochondrial myopathy and cardiomyopathy. Hum. Mol. Genet. 14 (2005) 3079-3088
17. Siciliano G., Tessa A., Petrini S., Mancuso M., Bruno C., Grieco G.S., Malandrini A., DeFlorio L., Martini B., Federico A., Nappi G., Santorelli F.M., and Murri L. Autosomal dominant external ophthalmoplegia and bipolar affective disorder associated with a mutation in the ANT1 gene. Neuromuscul. Disord. 13 (2003) 162-165
18. Komaki H., Fukazawa T., Houzen H., Yoshida K., Nonaka I., and Goto Y. A novel D104G mutation in the adenine nucleotide translocator 1 gene in autosomal dominant progressive external ophthalmoplegia patients with mitochondrial DNA with multiple deletions. Ann. Neurol. 51 (2002) 645-648
19. Chen X.J. Induction of an unregulated channel by mutations in adenine nucleotide translocase suggests an explanation for human ophthalmoplegia. Hum. Mol. Genet. 11 (2002) 1835-1843
20. Rousset S., del Mar Gonzalez-Barroso M., Gelly C., Pecqueur C., Bouillaud F., Ricquier D., and Cassard-Doulcier A.M. A new polymorphic site located in the human UCP1 gene controls the in vitro binding of CREB-like factor. Int. J. Obes. Relat. Metab. Disord. 26 (2002) 735-738
21. Shin H.D., Kim K.S., Cha M.H., and Yoon Y. The effects of UCP-1 polymorphisms on obesity phenotypes among Korean female subjects. Biochem. Biophys. Res. Commun. 335 (2005) 624-630
22. Urhammer S.A., Fridberg M., Sorensen T.I., Echwald S.M., Andersen T., Tybjaerg-Hansen A., Clausen J.O., and Pedersen O. Studies of genetic variability of the uncoupling protein 1 gene in Caucasian subjects with juvenile-onset obesity. J. Clin. Endocrinol. Metab. 82 (1997) 4069-4074
23. Fleury C., Neverova M., Collins S., Raimbault S., Champigny O., Levi-Meyrueis C., Bouillaud F., Seldin M.F., Surwit R.S., Ricquier D., and Warden C.H. Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat. Genet. 15 (1997) 269-272
24. Kovacs P., Ma L., Hanson R.L., Franks P., Stumvoll M., Bogardus C., and Baier L.J. Genetic variation in UCP2 (uncoupling protein-2) is associated with energy metabolism in Pima Indians. Diabetologia 48 (2005) 2292-2295
25. Maestrini S., Podesta F., Di Blasio A.M., Savia G., Brunani A., Tagliaferri A., Mencarelli M., Chiodini I., and Liuzzi A. Lack of association between UCP2 gene polymorphisms and obesity phenotype in Italian Caucasians. J. Endocrinol. Investig. 26 (2003) 985-990
26. Damcott C.M., Feingold E., Moffett S.P., Barmada M.M., Marshall J.A., Hamman R.F., and Ferrell R.E. Genetic variation in uncoupling protein 3 is associated with dietary intake and body composition in females. Metabolism 53 (2004) 458-464
27. Herrmann S.M., Wang J.G., Staessen J.A., Kertmen E., Schmidt-Petersen K., Zidek W., Paul M., and Brand E. Uncoupling protein 1 and 3 polymorphisms are associated with waist-to-hip ratio. J. Mol. Med. 81 (2003) 327-332
28. Argyropoulos G., Brown A.M., Willi S.M., Zhu J., He Y., Reitman M., Gevao S.M., Spruill I., and Garvey W.T. Effects of mutations in the human uncoupling protein 3 gene on the respiratory quotient and fat oxidation in severe obesity and type 2 diabetes. J. Clin. Invest. 102 (1998) 1345-1351
29. Mizuarai S., Miki S., Araki H., Takahashi K., and Kotani H. Identification of dicarboxylate carrier Slc25a10 as malate transporter in de novo fatty acid synthesis. J. Biol. Chem. 280 (2005) 32434-32441
30. Ramoz N., Reichert J.G., Smith C.J., Silverman J.M., Bespalova I.N., Davis K.L., and Buxbaum J.D. Linkage and association of the mitochondrial aspartate/glutamate carrier SLC25A12 gene with autism. Am. J. Psychiatry 161 (2004) 662-669
31. Hwu W.L., Kobayashi K., Hu Y.H., Yamaguchi N., Saheki T., Chou S.P., and Wang J.H. A Chinese adult onset type II citrullinaemia patient with 851del4/1638ins23 mutations in the SLC25A13 gene. J. Med. Genet. 38 (2001) E23
32. Saheki T., and Kobayashi K. Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD). J. Hum. Genet. 47 (2002) 333-341
33. Yamaguchi N., Kobayashi K., Yasuda T., Nishi I., Iijima M., Nakagawa M., Osame M., Kondo I., and Saheki T. Screening of SLC25A13 mutations in early and late onset patients with citrin deficiency and in the Japanese population: identification of two novel mutations and establishment of multiple DNA diagnosis methods for nine mutations. Human Mutat. 19 (2002) 122-130
34. Yasuda T., Yamaguchi N., Kobayashi K., Nishi I., Horinouchi H., Jalil M.A., Li M.X., Ushikai M., Iijima M., Kondo I., and Saheki T. Identification of two novel mutations in the SLC25A13 gene and detection of seven mutations in 102 patients with adult-onset type II citrullinemia. Hum. Genet. 107 (2000) 537-545
35. Yang X., Pratley R.E., Tokraks S., Tataranni P.A., and Permana P.A. UCP5/BMCP1 transcript isoforms in human skeletal muscle: relationship of the short-insert isoform with lipid oxidation and resting metabolic rates. Mol. Genet. Metab. 75 (2002) 369-373
36. Rosenberg M.J., Agarwala R., Bouffard G., Davis J., Fiermonte G., Hilliard M.S., Koch T., Kalikin L.M., Makalowska I., Morton D.H., Petty E.M., Weber J.L., Palmieri F., Kelley R.I., Schaffer A.A., and Biesecker L.G. Mutant deoxynucleotide carrier is associated with congenital microcephaly. Nat. Genet. 32 (2002) 175-179
37. Iacobazzi V., Pasquali M., Singh R., Matern D., Rinaldo P., Amat di San Filippo C., Palmieri F., and Longo N. Response to therapy in carnitine/acylcarnitine translocase (CACT) deficiency due to a novel missense mutation. Am. J. Med. Genet., A 126 (2004) 150-155
38. Iacobazzi V., Invernizzi F., Baratta S., Pons R., Chung W., Garavaglia B., Dionisi-Vici C., Ribes A., Parini R., Huertas M.D., Roldan S., Lauria G., Palmieri F., and Taroni F. Molecular and functional analysis of SLC25A20 mutations causing carnitine-acylcarnitine translocase deficiency. Human Mutat. 24 (2004) 312-320
39. Al Aqeel A.I., Rashid M.S., Ruiter J.P., Ijlst L., and Wanders R.J. A novel molecular defect of the carnitine acylcarnitine translocase gene in a Saudi patient. Clin. Genet. 64 (2003) 163-165
40. Costa C., Costa J.M., Slama A., Boutron A., Vequaud C., Legrand A., and Brivet M. Mutational spectrum and DNA-based prenatal diagnosis in carnitine-acylcarnitine translocase deficiency. Mol. Genet. Metab. 78 (2003) 68-73
41. Hsu B.Y., Iacobazzi V., Wang Z., Harvie H., Chalmers R.A., Saudubray J.M., Palmieri F., Ganguly A., and Stanley C.A. Aberrant mRNA splicing associated with coding region mutations in children with carnitine-acylcarnitine translocase deficiency. Mol. Genet. Metab. 74 (2001) 248-255
42. Grinberg M., Schwarz M., Zaltsman Y., Eini T., Niv H., Pietrokovski S., and Gross A. Mitochondrial carrier homolog 2 is a target of tBID in cells signaled to die by tumor necrosis factor alpha. Mol. Cell. Biol. 25 (2005) 4579-4590